Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Ischia

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
The Journal of Urology|December 3, 2014
HIF1α expression under normoxia in prostate cancer--which pathways to target?Weranja K B Ranasinghe, Graham S Baldwin, Damien Bolton, et al.
Life (Basel, Switzerland)|January 8, 2025
Stereotactic Body Therapy for Urologic Cancers-What the Urologist Needs to KnowJasamine Coles-Black, Adib Rahman, Shankar Siva, et al.
The Journal of Urology|August 25, 2014
Intraoperative registered transrectal ultrasound guidance for robot-assisted laparoscopic radical prostatectomyOmid Mohareri, Joseph Ischia, Peter C Black, et al.
BJU International|August 19, 2014
Identification of binding sites for C-terminal pro-gastrin-releasing peptide (GRP)-derived peptides in renal cell carcinoma: a potential target for future therapyJoseph Ischia, Oneel Patel, Kapil Sethi, et al.
British Journal of Clinical Pharmacology|March 20, 2021
Zinc supplementation as an adjunct therapy for COVID-19: Challenges and opportunitiesVidyasagar Chinni, John El-Khoury, Marlon Perera, et al.
BJUI Compass|September 26, 2024
ChatGPT and generative AI in urology and surgery-A narrative reviewShane Qin, Bodie Chislett, Joseph Ischia, et al.
BJU International|August 1, 2025
Oncological safety of testosterone replacement therapy in men with localised prostate cancer: a systematic review of observational studiesJordan Santucci, Peter Stapleton, Marlon Perera, et al.
Frontiers in Oncology|September 5, 2022
Role of PSMA PET-guided metastases-directed therapy in oligometastatic recurrent prostate cancerMatthew Alberto, Arthur Yim, Nathan Papa, et al.
BJU International|February 27, 2024
Lessons from a population-based bladder cancer registry: exploring why survival is not improvingJake A Tempo, Samuel Sii, Joseph Ischia, et al.
BJU International|April 24, 2019
Metformin may offer no protective effect in men undergoing external beam radiation therapy for prostate cancerWeranja K B Ranasinghe, Scott Williams, Joseph Ischia, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
The Journal of Urology|December 3, 2014
HIF1α expression under normoxia in prostate cancer--which pathways to target?Weranja K B Ranasinghe, Graham S Baldwin, Damien Bolton, et al.
Life (Basel, Switzerland)|January 8, 2025
Stereotactic Body Therapy for Urologic Cancers-What the Urologist Needs to KnowJasamine Coles-Black, Adib Rahman, Shankar Siva, et al.
The Journal of Urology|August 25, 2014
Intraoperative registered transrectal ultrasound guidance for robot-assisted laparoscopic radical prostatectomyOmid Mohareri, Joseph Ischia, Peter C Black, et al.
BJU International|August 19, 2014
Identification of binding sites for C-terminal pro-gastrin-releasing peptide (GRP)-derived peptides in renal cell carcinoma: a potential target for future therapyJoseph Ischia, Oneel Patel, Kapil Sethi, et al.
British Journal of Clinical Pharmacology|March 20, 2021
Zinc supplementation as an adjunct therapy for COVID-19: Challenges and opportunitiesVidyasagar Chinni, John El-Khoury, Marlon Perera, et al.
BJUI Compass|September 26, 2024
ChatGPT and generative AI in urology and surgery-A narrative reviewShane Qin, Bodie Chislett, Joseph Ischia, et al.
BJU International|August 1, 2025
Oncological safety of testosterone replacement therapy in men with localised prostate cancer: a systematic review of observational studiesJordan Santucci, Peter Stapleton, Marlon Perera, et al.
Frontiers in Oncology|September 5, 2022
Role of PSMA PET-guided metastases-directed therapy in oligometastatic recurrent prostate cancerMatthew Alberto, Arthur Yim, Nathan Papa, et al.
BJU International|February 27, 2024
Lessons from a population-based bladder cancer registry: exploring why survival is not improvingJake A Tempo, Samuel Sii, Joseph Ischia, et al.
BJU International|April 24, 2019
Metformin may offer no protective effect in men undergoing external beam radiation therapy for prostate cancerWeranja K B Ranasinghe, Scott Williams, Joseph Ischia, et al.
Pageof 6